↓ Skip to main content

Reversible eruption of neurofibromatosis associated with tofacitinib therapy for rheumatoid arthritis

Overview of attention for article published in Rheumatology, February 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
4 X users
reddit
1 Redditor

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Reversible eruption of neurofibromatosis associated with tofacitinib therapy for rheumatoid arthritis
Published in
Rheumatology, February 2019
DOI 10.1093/rheumatology/kez012
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Doctoral Student 3 18%
Student > Ph. D. Student 2 12%
Student > Master 2 12%
Student > Postgraduate 1 6%
Other 1 6%
Other 0 0%
Unknown 8 47%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 3 18%
Nursing and Health Professions 2 12%
Unspecified 1 6%
Biochemistry, Genetics and Molecular Biology 1 6%
Immunology and Microbiology 1 6%
Other 0 0%
Unknown 9 53%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 May 2026.
All research outputs
#20,171,041
of 31,768,658 outputs
Outputs from Rheumatology
#6,466
of 8,977 outputs
Outputs of similar age
#266,351
of 468,836 outputs
Outputs of similar age from Rheumatology
#75
of 91 outputs
Altmetric has tracked 31,768,658 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,977 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 468,836 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 91 others from the same source and published within six weeks on either side of this one. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.